Applied Clinical Trials Trends / Having trouble viewing this e-mail? Click Here

In this ISSUE

Europe Mulls Rival Approaches to Tackling Disease

Risk-Based Monitoring Versus Source Data Verification

Janssen Tackles Patient Connectivity

Regulatory
Sponsors Pilot New ICH E6 R2 Initiatives
In this article, Moe Alsumidaie will discuss QA updates.
... /Read more/
Advertisement
Introducing Cross-Trial Safety Notifications: Built for Efficiency, Vetted by Experience
On Demand
Learn More
Blockchain Technology
Blockchain Use in Research
The core tenets of blockchain technology–a decentralized and encrypted way of distributing, sharing, and storing information–seem appealing for health data.
... /Read more/
Advertisement
Introducing IQVIA ICF Author: The Power to Do Patient Consent Your Way
On Demand
Learn More

Calendar
/ 14th Biosimilars Summit 1/22/19-1/23/19 /
/ Clinical Data Disclosure and Transparency 1/29/19-1/30/19 /
/ Patient Registries and Real-World Evidence Summit 1/30/19-1/31/19 /
/ DIA Europe 2019 2/5/19-2/7/19 /
/ Making Clinical Research an Element of Better Healthcare 2/19/19-2/20/19 /
/ 2019 Bridging Clinical Research & Clinical Health Care Collaborative 3/4/19-3/5/19 /

Advertisement
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
On Demand
Learn More

Patient Centricity
Direct-to-Patient Clinical Trials: Strategies for Success
The exponential growth in the use of Direct-to-Patient clinical trials and the strategies pharmaceutical manufacturers should consider when implementing this model.
... /Read more/
Advertisement
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
On Demand
Learn More
Centralized Monitoring
The Basics of Clinical Trial Centralized Monitoring
Examining the practicality of implementing CM techniques to drive trial oversight efficiency while saving on-site monitoring resources and costs.
... /Read more/
Advertisement
The Potential for Disease-Modifying Therapies in Parkinson's Disease
On Demand
Learn More
BMS
BMS Operationalizes Study Connectivity
In this interview, Carolyn Brehm, BMS Study Connect Business Lead, will discuss how BMS is helping to match patients with studies through Study Connect.
... /Read more/
Ask the editor
Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise
Todd Baker
Group Publisher
todd.baker@ubm.com
website / blog / advertise / subscribe